paclitaxel,CTX-009
Compass Therapeutics
[]
$cmpx down 10.56% at $3.4882 (volume 121k, avgvolume 216k) in the last 20 min latest news: 5:00 pm est yesterday
compass therapeutics announces that the phase 2 data of ctx-009 in combination with paclitaxel in patients with biliary tract cancers ... 
Real-time penny stock alerts based on trading algorithms and breaking news; buy the dips and sell the rips.

Visit our website for more details.